Home | Community | Get Involved | Donate | | Site Index | Search Go Button
The mark, American Cancer Society, is a registered trademark of the American Cancer Society, Inc., and may not be copied, reproduced, transmitted, displayed, performed, distributed, sublicensed, altered, stored for subsequent use or otherwise used in whole or in part in any manner without ACS's prior written consent.
 
My Planner Register | Sign In Sign In


Cancer Reference Information
 
    All About This Topic
Other Information Sources
Glossary
Cancer Drug Guide
Treatment Options
Treatment Decision Tools
   
Detailed Guide: Bladder Cancer
Can Bladder Cancer Be Found Early?

Bladder cancer can sometimes be found early. Finding it early improves your chances that it can be treated successfully.

Screening

Screening tests or exams are used to look for a disease in people who have no symptoms (and who have not had that disease before).

One possible way to screen for bladder cancer is to check for blood in the urine (called hematuria). Blood in the urine is usually caused by benign conditions such as infections, but it can be the first sign of bladder cancer. Although large amounts of blood are can easily be seen, a test is needed to find small amounts. The test most often used is called urinalysis. But most studies of screening by using routine urinalysis to look for blood haven’t found more bladder cancers, although one study found that screening might detect the cancer at an earlier stage.

Another way to screen for bladder cancer is to examine the urine for cancer cells (urine cytology). This test does find some cancers, but it is not reliable enough to make a good screening test.

A newer test looks for a substance called NMP22 in the urine. When used in a large group of people being checked for bladder cancer, about half of the people found to have bladder cancer had abnormal results on this test. The people being checked either had symptoms of bladder cancer (such as blood in the urine) or were at high risk of bladder cancer because they smoked. The NMP22 test did find a few cases of bladder cancer that were missed by cystoscopy (this procedure is described in "How is bladder cancer diagnosed?"). Still, some people with abnormal results did not actually have cancer at all, and this test missed almost half of the cases of bladder cancer. Right now, the test for NMP22 seems to be better suited for use in patients who have had a bladder cancer removed to check for cancer recurrence.

Another promising test looks for telomerase in the urine. Telomerase is an enzyme that is found often in cancer cells. Still, experts feel that more studies need to be done before any test becomes useful for widespread screening for bladder cancer.

Screening the general public for bladder cancer is not recommended by any professional organization. Some doctors recommend bladder cancer screening for people at very high risk. Risk factors that would justify screening include a previous diagnosis of bladder cancer or certain birth defects of the bladder. People with a lot of work-related exposure to certain chemicals might also be screened. This has been done in the past, usually by a combination of microscopic examination of urine for cancer cells (urine cytology) and viewing the bladder through a thin lighted tube (cystoscopy).

If you don't have any known risk factors, prompt attention to bladder symptoms is the best advice for finding bladder cancer in its earliest, most treatable stages.

Last Medical Review: 01/27/2009
Last Revised: 5/13/2009

Printer-Friendly Page
Email this Page
Overview
Detailed Guide
What Is It?
Causes, Risk Factors and Prevention
Early Detection, Diagnosis, Staging
Treating Bladder Cancer
Talking With Your Doctor
More Information
Related Tools & Topics
Prevention & Early Detection  
Bookstore  
Circle Of Sharing: Personalize Your Cancer Information  
Not registered yet?
  Register now or see reasons to register.  
Help |  About ACS |  Employment & Volunteer Opportunities |  Legal & Privacy Information |  Press Room
Copyright 2009 © American Cancer Society, Inc.
All content and works posted on this website are owned and
copyrighted by the American Cancer Society, Inc. All rights reserved.